Caregen
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Supplier, engineering
Caregen is a South Korean biotechnology company specializing in synthetic functional peptides since 2001. With over 1,200 proprietary peptides developed, Caregen has commercialized innovative solutions across nutraceuticals and pharmaceuticals.
Key pipeline assets:
- Korglutide: oral GLP-1 peptide powder for weight loss without common side effects
- MyoKi: myostatin-inhibiting peptide enhancing muscle mass and strength
- ProGsterol: metabolic peptide improving insulin receptor sensitivity to regulate glucose
- CG-P5: VEGFR2-inhibiting peptide eye drop for wet AMD (U.S. Phase 1 trial)
- CG-T1: peptide-based topical drug for dry eye, targeting inflammation and oxidative stress
Caregen delivers integrated peptide healthcare solutions spanning therapeutics, functional foods, and medical devices, and actively seeks global licensing and co-development partners.
With the world’s largest peptide IP portfolio held by a single entity, Caregen is well-positioned for strategic global partnerships.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}